Impact of Prescriber Nonresponse on Patient Representativeness

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Epidemiology

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/EDE.0b013e31816326e9PMID 18300697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparing different methods to detect and correct nonresponse bias in postal questionnaire studies.

  2007cited by this paper
• The CADEUS study: methods and logistics

  2007cited by this paper
• Channelling of COX‐2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study

  2007cited by this paper
• The Funen Neck and Chest Pain Study: Analysing Non-Response Bias by Using National Vital Statistic Data

  2006cited by this paper
• Serious Skin Reactions and Selective COX-2 Inhibitors

  2006cited by this paper
• A Comparison of Reported Gastrointestinal and Thromboembolic Events Between Rofecoxib and Celecoxib Using Observational Data

  2005cited by this paper
• Increasing response to a postal survey of sedentary patients – a randomised controlled trial [ISRCTN45665423]

  2004cited by this paper
• Studies with low response proportions may be less biased than studies with high response proportions.

  2004cited by this paper
• A Structural Approach to Selection Bias

  2004cited by this paper
• Does non-responder bias have a significant effect on the results in a postal questionnaire study?

  2004cited by this paper
• Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription‐Event Monitoring data

  2004cited by this paper
• Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.

  2003cited by this paper
• Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data.

  2003cited by this paper
• Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.

  2003cited by this paper
• The impact of survey nonresponse bias on conclusions drawn from a mammography intervention trial.

  2003cited by this paper
• Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.

  2003cited by this paper
• A high response is not essential to prevent selection bias: results from the Leiden 85-plus study.

  2002cited by this paper
• Encyclopedia of Epidemiologic Methods

  2002cited by this paper
• Appel téléphonique ou lettre de relance pour améliorer le taux de réponse des investigateurs ? Un essai randomisé dans le cadre du Réseau Sentinelles.

  2001cited by this paper
• Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects

  2001cited by this paper
• [Phone prompt or mailed reminder for increasing response rate among investigators? A randomized trial in the Sentinelles network].

  2001cited by this paper
• [Nonparticipation as a factor influencing the value of follow-up studies. Results of a telephone 5-year follow-up interview of 55-74-year-old participants of the Augsburg 1989/90 MONICA Survey].

  1997cited by this paper
• The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) Study Investigators.

  1996cited by this paper

• Quality of Life and Pain During Treatment of Metastatic Castration-resistant Prostate Cancer With Cabazitaxel In Routine Clinical Practice.

  2020cites this paper
• Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort

  2019cites this paper
• Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study

  2019cites this paper
• Assessing the representativeness of physician and patient respondents to a primary care survey using administrative data

  2018cites this paper
• Real-time black carbon personal exposure levels in microenvironments: Home to home on a round-trip, Hanoi–Singapore

  2018cites this paper
• Real‐life patterns of use, safety and effectiveness of sunitinib in first‐line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study

  2017cites this paper
• Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients

  2017cites this paper
• Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study

  2014cites this paper
• Obesity-Related Factors in Turkish School Children

  2012cites this paper
• Use of health insurance claim patterns to identify patients using nonsteroidal anti‐inflammatory drugs for rheumatoid arthritis

  2012cites this paper
• The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.

  2011cites this paper
• Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.

  2010cites this paper
• When Patients Report Diseases That Prescribers Seem Unaware of: Discordance Between Patient and Physician Reporting of Risk‐Related Previous History in NSAID Users From the CADEUS Study

  2010cites this paper
• [Terminology used in publications of pharmacoepidemiological research in france using health insurance reimbursement databases: need for harmonisation].

  2010cites this paper
• Pharmacoepidemiological research using French reimbursement databases: yes we can!

  2010cites this paper
• Terminologie utilisée concernant les bases de remboursement de l’assurance maladie en pharmaco-épidémiologie : une harmonisation nécessaire

  2010cites this paper
• French national health insurance information system and the permanent beneficiaries sample.

  2010cites this paper
• Concordance between prescriber‐ and patient‐reported previous medical history and NSAID indication in the CADEUS cohort

  2010cites this paper
• The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.

  2009cites this paper